173 related articles for article (PubMed ID: 19380636)
1. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme.
Malynn BA; Ma A
J Exp Med; 2009 May; 206(5):977-80. PubMed ID: 19380636
[TBL] [Abstract][Full Text] [Related]
2. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NF-κB signaling by the A20 deubiquitinase.
Shembade N; Harhaj EW
Cell Mol Immunol; 2012 Mar; 9(2):123-30. PubMed ID: 22343828
[TBL] [Abstract][Full Text] [Related]
4. [Significance of A20 in B-cell lymphomas].
Kato M; Ogawa S
Rinsho Ketsueki; 2011 Apr; 52(4):190-7. PubMed ID: 21566404
[No Abstract] [Full Text] [Related]
5. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
6. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
[TBL] [Abstract][Full Text] [Related]
8. A20 in inflammation and autoimmunity.
Catrysse L; Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2014 Jan; 35(1):22-31. PubMed ID: 24246475
[TBL] [Abstract][Full Text] [Related]
9. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
[TBL] [Abstract][Full Text] [Related]
10. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
12. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
Yamaguchi N; Yamaguchi N
FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
[TBL] [Abstract][Full Text] [Related]
13. Frequent inactivation of A20 through gene mutation in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Akatsuka M; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Rinsho Ketsueki; 2011 Jun; 52(6):313-9. PubMed ID: 21737982
[No Abstract] [Full Text] [Related]
14. Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma.
Nocturne G; Tarn J; Boudaoud S; Locke J; Miceli-Richard C; Hachulla E; Dubost JJ; Bowman S; Gottenberg JE; Criswell LA; Lessard CJ; Sivils KL; Carapito R; Bahram S; Seror R; Ng WF; Mariette X
Ann Rheum Dis; 2016 Apr; 75(4):780-3. PubMed ID: 26338037
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of Hodgkin lymphoma.
Küppers R
Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.
Tavares RM; Turer EE; Liu CL; Advincula R; Scapini P; Rhee L; Barrera J; Lowell CA; Utz PJ; Malynn BA; Ma A
Immunity; 2010 Aug; 33(2):181-91. PubMed ID: 20705491
[TBL] [Abstract][Full Text] [Related]
17. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma.
Nomoto J; Hiramoto N; Kato M; Sanada M; Maeshima AM; Taniguchi H; Hosoda F; Asakura Y; Munakata W; Sekiguchi N; Maruyama D; Watanabe T; Nakagama H; Takeuchi K; Tobinai K; Ogawa S; Kobayashi Y
BMC Cancer; 2012 Oct; 12():457. PubMed ID: 23039325
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I
Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243
[TBL] [Abstract][Full Text] [Related]
20. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
